Cite
HARVARD Citation
Shin, J. et al. (2022). Angiotensin‐converting enzyme inhibitors versus angiotensin receptor blockers: New‐onset diabetes mellitus stratified by statin use. Journal of clinical pharmacy and therapeutics. pp. 97-103. [Online].